TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/21 17:25 | 3/17/21 | CDMO | Avid Bioservices, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bamforth Mark R | CA | D | P | 2,291 | 18.18 | 0 | 126 | New | 126 | M | |||||||||||||||
3/16/20 15:24 | 3/13/20 | CDMO | Avid Bioservices, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bamforth Mark R | CA | D | P | 104 | 4.01 | 0 | 26 | 26 | 126 | I | |||||||||||||||
2/20/18 18:13 | 2/15/18 | CDMO | Avid Bioservices, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bamforth Mark R | CA | D | P | 113 | 2.25 | 0 | 50 | 100 | 100 | D | |||||||||||||||
10/27/17 18:15 | 10/27/17 | PPHM | Peregrine Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Bamforth Mark R | CA | D | P | 225 | 4.50 | 0 | 50 | New | 50 | D | |||||||||||||||
3/6/09 10:58 | 3/4/09 | GENZ | Genzyme Corp | MA | Health | BioPrd | Biological Products, (No Diag | Bamforth Mark R | MA | O | Sr.VP,Co | P | 38 | 54.54 | 0 | 1 | 18 | 5 | B |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |